Efficacy and Safety of Ceritinib 450 mg/day with Food and 750 mg/day in Fasted State in Treatment-Naïve Patients with ALK+ Non–Small Cell Lung Cancer: Results from the ASCEND-8 Asi...

por Cho, Byoung Chul, Kim, Dong-Wan, Batra, Ullas, Park, Keunchil, Kim, Sang-We, Yang, Cheng-Ta, Voon, Pei-Jye, Sriuranpong, Virote, Babu, K. Govind, Amin, Khalid, Wang, Yingbo, Sen, Paramita, Slimane, Khemaies, Geater, Sarayut
Publicado 2023

Ceritinib Efficacy and Safety in Treatment-Naive Asian Patients With Advanced ALK-Rearranged NSCLC: An ASCEND-4 Subgroup Analysis

por Tan, Daniel S.W., Geater, Sarayut, Yu, Chong-Jen, Tsai, Chun-Ming, Hsia, Te-Chun, Chen, Jun, Lin, Meng-Chih, Lu, You, Sriuranpong, Virote, Yang, Cheng-Ta, Sen, Paramita, Branle, Fabrice, Shi, Michael, Wu, Yi-Long
Publicado 2020